Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.47% vs 3.82% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 29.95% vs -90.18% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -6.70% vs 19.04% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 20.29% vs -47.33% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of TTK Healthcare With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
801.49
2,494.49
-1,693.00
-67.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
801.49
2,494.49
-1,693.00
-67.87%
Raw Material Cost
195.34
1,592.19
-1,396.85
-87.73%
Purchase of Finished goods
186.95
55.67
131.28
235.82%
(Increase) / Decrease In Stocks
-13.37
-1.81
-11.56
-638.67%
Employee Cost
150.91
255.43
-104.52
-40.92%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
246.84
296.45
-49.61
-16.73%
Total Expenditure (Excl Depreciation)
766.67
2,197.93
-1,431.26
-65.12%
Operating Profit (PBDIT) excl Other Income
34.82
296.56
-261.74
-88.26%
Other Income
71.25
83.14
-11.89
-14.30%
Operating Profit (PBDIT)
106.07
379.70
-273.63
-72.06%
Interest
3.32
16.30
-12.98
-79.63%
Exceptional Items
13.91
0.00
13.91
Gross Profit (PBDT)
116.66
363.40
-246.74
-67.90%
Depreciation
8.33
49.61
-41.28
-83.21%
Profit Before Tax
108.33
313.79
-205.46
-65.48%
Tax
26.67
80.99
-54.32
-67.07%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
81.66
232.80
-151.14
-64.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
81.66
232.80
-151.14
-64.92%
Equity Capital
14.13
171.00
-156.87
-91.74%
Face Value
10.00
10.00
0.00
Reserves
1,046.50
1,356.95
-310.45
-22.88%
Earnings per share (EPS)
57.79
13.61
44.18
324.61%
Diluted Earnings per share
57.79
13.61
44.18
324.61%
Operating Profit Margin (Excl OI)
4.34%
11.89%
0.00
-7.55%
Gross Profit Margin
14.56%
14.57%
0.00
-0.01%
PAT Margin
10.19%
9.33%
0.00
0.86%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 801.49 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.47% vs 3.82% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 81.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.95% vs -90.18% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 34.82 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.70% vs 19.04% in Mar 2024
Annual - Interest
Interest 3.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.29% vs -47.33% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.34%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
